Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
AJR. American Journal of Roentgenology
|
November 18, 2004
MRI guidance of focused ultrasound therapy of uterine fibroids: early results
Jonathan Hindley, Wladyslaw M Gedroyc, Lesley Regan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2015
Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
Ankita Gupte, Emma K Baker, Soo-San Wan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A
Wayne L Furman, Beth McCarville, Barry L Shulkin, et al.
Pediatric Blood & Cancer
|
June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force
Sarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Journal of Clinical Medicine
|
April 30, 2021
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force
Holly L Pacenta, Wendy Allen-Rhoades, David Langenau, et al.
Cell Reports
|
December 2, 2014
Targeting the DNA repair pathway in Ewing sarcoma
Elizabeth Stewart, Ross Goshorn, Cori Bradley, et al.
Nature
|
August 31, 2017
Orthotopic patient-derived xenografts of paediatric solid tumours
Elizabeth Stewart, Sara M Federico, Xiang Chen, et al.
Nature Communications
|
February 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid
Min Pan, Yinwen Zhang, William C Wright, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid
Min Pan, Yinwen Zhang, William C Wright, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2019
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma
Wayne L Furman, Sara M Federico, Mary Beth McCarville, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
AJR. American Journal of Roentgenology
|
November 18, 2004
MRI guidance of focused ultrasound therapy of uterine fibroids: early results
Jonathan Hindley, Wladyslaw M Gedroyc, Lesley Regan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2015
Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
Ankita Gupte, Emma K Baker, Soo-San Wan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A
Wayne L Furman, Beth McCarville, Barry L Shulkin, et al.
Pediatric Blood & Cancer
|
June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force
Sarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Journal of Clinical Medicine
|
April 30, 2021
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force
Holly L Pacenta, Wendy Allen-Rhoades, David Langenau, et al.
Cell Reports
|
December 2, 2014
Targeting the DNA repair pathway in Ewing sarcoma
Elizabeth Stewart, Ross Goshorn, Cori Bradley, et al.
Nature
|
August 31, 2017
Orthotopic patient-derived xenografts of paediatric solid tumours
Elizabeth Stewart, Sara M Federico, Xiang Chen, et al.
Nature Communications
|
February 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid
Min Pan, Yinwen Zhang, William C Wright, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid
Min Pan, Yinwen Zhang, William C Wright, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2019
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma
Wayne L Furman, Sara M Federico, Mary Beth McCarville, et al.
Page
of 14